44.03
price down icon3.49%   -1.59
pre-market  プレマーケット:  43.88   -0.15   -0.34%
loading
前日終値:
$45.62
開ける:
$46.18
24時間の取引高:
1.34M
Relative Volume:
1.10
時価総額:
$3.52B
収益:
-
当期純損益:
$-269.44M
株価収益率:
-11.74
EPS:
-3.75
ネットキャッシュフロー:
$-262.63M
1週間 パフォーマンス:
-6.20%
1か月 パフォーマンス:
-9.44%
6か月 パフォーマンス:
-1.12%
1年 パフォーマンス:
+67.41%
1日の値動き範囲:
Value
$43.08
$46.18
1週間の範囲:
Value
$43.08
$47.67
52週間の値動き範囲:
Value
$21.34
$58.40

Akero Therapeutics Inc Stock (AKRO) Company Profile

Name
名前
Akero Therapeutics Inc
Name
セクター
Healthcare (1151)
Name
電話
650-487-6488
Name
住所
601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA
Name
職員
67
Name
Twitter
@akerotx
Name
次回の収益日
2025-08-08
Name
最新のSEC提出書
Name
AKRO's Discussions on Twitter

AKRO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AKRO
Akero Therapeutics Inc
44.03 3.63B 0 -269.44M -262.63M -3.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Akero Therapeutics Inc Stock (AKRO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-04 開始されました TD Cowen Buy
2025-01-30 アップグレード BofA Securities Neutral → Buy
2025-01-27 繰り返されました H.C. Wainwright Buy
2024-11-18 開始されました Citigroup Buy
2024-04-22 再開されました BofA Securities Neutral
2023-09-19 開始されました Cantor Fitzgerald Overweight
2023-08-28 開始されました UBS Buy
2023-01-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-09-14 アップグレード Evercore ISI In-line → Outperform
2021-10-19 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-09-10 開始されました BofA Securities Buy
2021-02-26 開始されました Guggenheim Buy
2020-09-10 開始されました Morgan Stanley Overweight
2020-07-20 繰り返されました H.C. Wainwright Buy
2020-07-07 開始されました Chardan Capital Markets Buy
2020-07-01 繰り返されました H.C. Wainwright Buy
2020-03-02 開始されました H.C. Wainwright Buy
2020-02-10 開始されました Canaccord Genuity Buy
2019-07-15 開始されました Evercore ISI Outperform
2019-07-15 開始されました JP Morgan Overweight
2019-07-15 開始されました Jefferies Buy
2019-07-15 開始されました ROTH Capital Buy
すべてを表示

Akero Therapeutics Inc (AKRO) 最新ニュース

pulisher
Sep 04, 2025

Propel Bio Management LLC Reduces Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat

Sep 04, 2025
pulisher
Sep 04, 2025

Akero Therapeutics, Inc. $AKRO Holdings Lowered by Alkeon Capital Management LLC - MarketBeat

Sep 04, 2025
pulisher
Sep 04, 2025

ADAR1 Capital Management LLC Has $2.88 Million Stock Position in Akero Therapeutics, Inc. $AKRO - MarketBeat

Sep 04, 2025
pulisher
Sep 04, 2025

Redmile Group LLC Sells 295,932 Shares of Akero Therapeutics, Inc. $AKRO - MarketBeat

Sep 04, 2025
pulisher
Sep 04, 2025

Baker BROS. Advisors LP Trims Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat

Sep 04, 2025
pulisher
Sep 04, 2025

Should you wait for a breakout in Akero Therapeutics Inc.Market Volume Report & Advanced Swing Trade Entry Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Best data tools to analyze Akero Therapeutics Inc. stockMarket Volume Report & Advanced Swing Trade Entry Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Will Akero Therapeutics Inc. continue its uptrendJuly 2025 Earnings & Verified High Yield Trade Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Chart based exit strategy for Akero Therapeutics Inc.July 2025 Short Interest & AI Based Buy and Sell Signals - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

7,221 Shares in Akero Therapeutics, Inc. $AKRO Acquired by HighTower Advisors LLC - MarketBeat

Sep 04, 2025
pulisher
Sep 04, 2025

Can Akero Therapeutics Inc. disrupt its industryTrade Risk Summary & Risk Controlled Stock Alerts - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Risk vs reward if holding onto Akero Therapeutics Inc.2025 Market Overview & Fast Moving Trade Plans - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Northern Trust Corp Has $26.59 Million Stake in Akero Therapeutics, Inc. $AKRO - MarketBeat

Sep 04, 2025
pulisher
Sep 04, 2025

How to build a dashboard for Akero Therapeutics Inc. stockWeekly Trade Report & Precise Swing Trade Entry Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

16,473 Shares in Akero Therapeutics, Inc. $AKRO Acquired by FORA Capital LLC - MarketBeat

Sep 04, 2025
pulisher
Sep 04, 2025

Historical volatility pattern of Akero Therapeutics Inc. visualized2025 Trade Ideas & Weekly Top Performers Watchlists - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can trapped investors hope for a rebound in Akero Therapeutics Inc.July 2025 Intraday Action & Accurate Trade Setup Notifications - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How to interpret RSI for Akero Therapeutics Inc. stockEarnings Overview Summary & AI Driven Stock Movement Reports - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Akero Therapeutics, Inc. $AKRO Position Trimmed by Tema Etfs LLC - MarketBeat

Sep 03, 2025
pulisher
Sep 03, 2025

How to escape a deep drawdown in Akero Therapeutics Inc.Treasury Yields & Real-Time Stock Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Akero Therapeutics Inc. stock daily chart insightsBear Alert & Real-Time Volume Surge Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Key resistance and support levels for Akero Therapeutics Inc.Weekly Investment Summary & AI Optimized Trade Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 20:48:57 - beatles.ru

Sep 03, 2025
pulisher
Sep 03, 2025

Akero Therapeutics Inc. recovery potential after sell off2025 Fundamental Recap & Weekly High Return Forecasts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using flow based indicators on Akero Therapeutics Inc.2025 Market Overview & Smart Allocation Stock Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Akero Therapeutics Inc. deliver alphaJuly 2025 Drop Watch & High Accuracy Swing Entry Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Intraday pattern recognizer results for Akero Therapeutics Inc.Rate Hike & AI Enhanced Trading Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Walleye Capital LLC Decreases Stock Holdings in Akero Therapeutics, Inc. $AKRO - MarketBeat

Sep 03, 2025
pulisher
Sep 03, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Given Average Rating of "Buy" by Analysts - MarketBeat

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 02:35:46 - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Chart overlay techniques for tracking Akero Therapeutics Inc.Quarterly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Akero Therapeutics, Inc. $AKRO Shares Purchased by Long Focus Capital Management LLC - MarketBeat

Sep 03, 2025
pulisher
Sep 03, 2025

Market reaction to Akero Therapeutics Inc.’s recent newsEarnings Overview Summary & Weekly Breakout Stock Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What MACD and RSI say about Akero Therapeutics Inc.Weekly Trade Summary & Growth Oriented Trading Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How cyclical is Akero Therapeutics Inc.’s revenue streamVolume Spike & Free Technical Pattern Based Buy Signals - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Is Akero Therapeutics Inc. forming a reversal pattern2025 Support & Resistance & Fast Gain Swing Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Akero Therapeutics Inc. price bounce be sustainable2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How does Akero Therapeutics Inc. compare to its peersJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 02, 2025

Exit strategy if you’re trapped in Akero Therapeutics Inc.Quarterly Earnings Summary & Free Weekly Watchlist of Top Performers - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Akero Therapeutics, Inc. $AKRO Shares Acquired by Invesco Ltd. - MarketBeat

Sep 02, 2025
pulisher
Sep 02, 2025

How does Akero Therapeutics Inc. score in quality rankingsProfit Target & Expert Approved Momentum Trade Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Smart tools for monitoring Akero Therapeutics Inc.’s price action2025 Geopolitical Influence & Growth Focused Entry Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can Akero Therapeutics Inc. rally from current levelsTrade Signal Summary & Long-Term Safe Investment Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Candlestick signals on Akero Therapeutics Inc. stock today2025 Valuation Update & Safe Capital Growth Stock Tips - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Aug Gainers: What’s Akero Therapeutics Inc.’s historical returnQuarterly Investment Review & Low Risk High Win Rate Stock Picks - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Candlestick Reversal Detected on Akero Therapeutics Inc.’s ChartLayoff News & Accurate Technical Buy Alerts - beatles.ru

Sep 01, 2025
pulisher
Sep 01, 2025

What’s Akero Therapeutics Inc.’s historical returnPortfolio Gains Report & Weekly Hot Stock Watchlists - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Aug Rallies: Will Akero Therapeutics Inc. benefit from rising consumer demandTrade Exit Report & Low Risk Entry Point Tips - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Akero Therapeutics Inc. Stages Intraday Comeback — Trend ChangeQuarterly Trade Report & Low Risk High Reward Ideas - beatles.ru

Sep 01, 2025
pulisher
Sep 01, 2025

Will Akero Therapeutics Inc. benefit from rising consumer demand2025 Market WrapUp & Weekly Top Gainers Trade List - khodrobank.com

Sep 01, 2025

Akero Therapeutics Inc (AKRO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Akero Therapeutics Inc (AKRO) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Young Jonathan
Chief Operating Officer
Aug 12 '25
Option Exercise
21.10
12,500
263,750
209,984
Young Jonathan
Chief Operating Officer
Aug 12 '25
Sale
47.79
12,500
597,326
197,484
Cheng Andrew
President and CEO
Aug 11 '25
Sale
48.59
30,000
1,457,596
490,757
Henderson Jane
Director
Aug 12 '25
Option Exercise
7.01
3,000
21,027
12,398
Henderson Jane
Director
Aug 12 '25
Sale
47.46
3,000
142,371
9,398
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
大文字化:     |  ボリューム (24 時間):